Cargando…
Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report
BACKGROUND: Pulmonary arterial hypertension (PAH) is a rare, progressive, fatal vascular disorder. Genetic predisposition plays vital roles in the development of PAH, with most mutations being identified in genes involved in the transforming growth factor beta (TGF-β) signaling pathways. Defects in...
Autores principales: | Wang, Guoliang, Fan, Rui, Ji, Ruirui, Zou, Wenxin, Penny, Daniel J., Varghese, Nidhy P., Fan, Yuxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722683/ https://www.ncbi.nlm.nih.gov/pubmed/26801773 http://dx.doi.org/10.1186/s12890-016-0183-7 |
Ejemplares similares
-
Hereditary pulmonary arterial hypertension burden in pediatrics: A single referral center experience
por: Ishizuka, Maki, et al.
Publicado: (2023) -
Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an “HHT‐like” syndrome in children
por: Hodgson, Joshua, et al.
Publicado: (2021) -
Functional Changes in Pulmonary Arterial Endothelial Cells Associated with BMPR2 Mutations
por: Wang, Hu, et al.
Publicado: (2014) -
Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia: A Review
por: Varghese, Nidhy, et al.
Publicado: (2019) -
Novel homozygous nonsense mutation of MLIP and compensatory alternative splicing
por: Mezreani, Jean, et al.
Publicado: (2022)